KIAA1363 affects retinyl ester turnover in cultured murine and human hepatic stellate cells.


Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
03 2022
Historique:
received: 08 10 2021
revised: 14 12 2021
accepted: 19 01 2022
pubmed: 2 2 2022
medline: 27 4 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Large quantities of vitamin A are stored as retinyl esters (REs) in specialized liver cells, the hepatic stellate cells (HSCs). To date, the enzymes controlling RE degradation in HSCs are poorly understood. In this study, we identified KIAA1363 (also annotated as arylacetamide deacetylase 1 or neutral cholesterol ester hydrolase 1) as a novel RE hydrolase. We show that KIAA1363 is expressed in the liver, mainly in HSCs, and exhibits RE hydrolase activity at neutral pH. Accordingly, addition of the KIAA1363-specific inhibitor JW480 largely reduced RE hydrolase activity in lysates of cultured murine and human HSCs. Furthermore, cell fractionation experiments and confocal microscopy studies showed that KIAA1363 localizes to the endoplasmic reticulum. We demonstrate that overexpression of KIAA1363 in cells led to lower cellular RE content after a retinol loading period. Conversely, pharmacological inhibition or shRNA-mediated silencing of KIAA1363 expression in cultured murine and human HSCs attenuated RE degradation. Together, our data suggest that KIAA1363 affects vitamin A metabolism of HSCs by hydrolyzing REs at the endoplasmic reticulum, thereby counteracting retinol esterification and RE storage in lipid droplets.

Identifiants

pubmed: 35101424
pii: S0022-2275(22)00006-2
doi: 10.1016/j.jlr.2022.100173
pmc: PMC8953624
pii:
doi:

Substances chimiques

Retinyl Esters 0
Vitamin A 11103-57-4
Hydrolases EC 3.-
Carboxylic Ester Hydrolases EC 3.1.1.-
Nceh1 protein, mouse EC 3.1.1.-
NCEH1 protein, human EC 3.1.1.13
Sterol Esterase EC 3.1.1.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100173

Subventions

Organisme : Austrian Science Fund FWF
ID : I 3535
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 31638
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 34899
Pays : Austria

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

Chem Biol. 2011 Apr 22;18(4):476-84
pubmed: 21513884
Pharmacotherapy. 2000 Mar;20(3):270-9
pubmed: 10730683
J Lipid Res. 2009 Dec;50(12):2514-23
pubmed: 19723663
J Nutr. 1988 Nov;118(11):1331-5
pubmed: 3193250
Arch Biochem Biophys. 2016 Jan 15;590:72-81
pubmed: 26617293
J Lipid Res. 2010 Feb;51(2):274-85
pubmed: 19592704
BMC Mol Cell Biol. 2020 Apr 22;21(1):32
pubmed: 32321446
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Aug;1865(8):158730
pubmed: 32361002
J Biol Chem. 2018 May 4;293(18):6958-6968
pubmed: 29555681
Biochim Biophys Acta. 2015 Jul;1851(7):937-45
pubmed: 25732851
Cell Metab. 2009 Sep;10(3):219-28
pubmed: 19723498
RNA. 2003 Apr;9(4):493-501
pubmed: 12649500
FASEB J. 2009 Jul;23(7):2307-16
pubmed: 19246492
Biochim Biophys Acta. 2014 Apr 4;1841(4):574-80
pubmed: 24369119
Hepatol Commun. 2019 Jul 15;3(9):1191-1204
pubmed: 31497741
J Biol Chem. 2008 Nov 28;283(48):33357-64
pubmed: 18782767
J Lipid Res. 2016 Jul;57(7):1162-74
pubmed: 27179362
J Lipid Res. 2014 Oct;55(10):2033-40
pubmed: 24868095
Physiol Rev. 2008 Jan;88(1):125-72
pubmed: 18195085
J Clin Endocrinol Metab. 2015 Dec;100(12):E1568-74
pubmed: 26439088
J Lipid Res. 2010 Oct;51(10):2896-908
pubmed: 20625037
Biosci Rep. 2021 Jan 29;41(1):
pubmed: 33350435
J Nutr. 2015 Aug;145(8):1687-91
pubmed: 26136587
J Biol Chem. 2016 Aug 19;291(34):17977-87
pubmed: 27354281
Science. 1990 Oct 19;250(4979):399-404
pubmed: 2218545
J Hepatol. 2015 Aug;63(2):437-45
pubmed: 25733154
J Lipid Res. 2000 Dec;41(12):2024-34
pubmed: 11108736
Subcell Biochem. 2016;81:95-125
pubmed: 27830502
Clin Transl Sci. 2021 May;14(3):976-989
pubmed: 33382909
N Engl J Med. 1984 Apr 19;310(16):1023-31
pubmed: 6369133
J Lipid Res. 2016 Jan;57(1):131-41
pubmed: 26423520
Biochem Biophys Res Commun. 2011 Jan 7;404(1):254-60
pubmed: 21111707
Chem Res Toxicol. 2006 Sep;19(9):1142-50
pubmed: 16978018
Circ Res. 2011 May 13;108(10):e13
pubmed: 21566218
Hum Mol Genet. 2014 Aug 1;23(15):4077-85
pubmed: 24670599
Chem Biol. 2006 Oct;13(10):1041-50
pubmed: 17052608
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Sep;1864(9):1258-1267
pubmed: 31150775
PLoS One. 2017 May 4;12(5):e0176980
pubmed: 28472192
Circ Res. 2010 Nov 26;107(11):1387-95
pubmed: 20947831
Methods Enzymol. 1990;190:58-71
pubmed: 1965004
Biochim Biophys Acta. 2000 Jan 17;1483(2):251-62
pubmed: 10634941

Auteurs

Carina Wagner (C)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

Victoria Hois (V)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

Annalena Eggeling (A)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

Lisa-Maria Pusch (LM)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

Laura Pajed (L)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria.

Patrick Starlinger (P)

Department of Surgery, General Hospital, Medical University of Vienna, Vienna, Austria; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Thierry Claudel (T)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Michael Trauner (M)

Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Robert Zimmermann (R)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria.

Ulrike Taschler (U)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria. Electronic address: ulrike.taschler@uni-graz.at.

Achim Lass (A)

Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria; Field of Excellence BioHealth, University of Graz, Graz, Austria. Electronic address: achim.lass@uni-graz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH